These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16319910)

  • 1. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.
    Newton TF; Roache JD; De La Garza R; Fong T; Wallace CL; Li SH; Elkashef A; Chiang N; Kahn R
    Neuropsychopharmacology; 2006 Jul; 31(7):1537-44. PubMed ID: 16319910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory.
    Tolliver BK; McRae-Clark AL; Saladin M; Price KL; Simpson AN; DeSantis SM; Baker NL; Brady KT
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):106-13. PubMed ID: 20337507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion sustained release treatment decreases craving for video games and cue-induced brain activity in patients with Internet video game addiction.
    Han DH; Hwang JW; Renshaw PF
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):297-304. PubMed ID: 20695685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.
    Culbertson CS; Bramen J; Cohen MS; London ED; Olmstead RE; Gan JJ; Costello MR; Shulenberger S; Mandelkern MA; Brody AL
    Arch Gen Psychiatry; 2011 May; 68(5):505-15. PubMed ID: 21199957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men.
    Das M; Santos D; Matheson T; Santos GM; Chu P; Vittinghoff E; Shoptaw S; Colfax GN
    AIDS; 2010 Apr; 24(7):991-1000. PubMed ID: 20397286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior.
    Reichel CM; Linkugel JD; Bevins RA
    Pharmacol Biochem Behav; 2008 May; 89(3):463-72. PubMed ID: 18329085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intravenous methamphetamine administration during treatment with bupropion.
    Newton TF; Roache JD; De La Garza R; Fong T; Wallace CL; Li SH; Elkashef A; Chiang N; Kahn R
    Psychopharmacology (Berl); 2005 Nov; 182(3):426-35. PubMed ID: 16163531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Induced Craving for Methamphetamine Is Associated With Neural Methamphetamine Cue Reactivity.
    Grodin EN; Courtney KE; Ray LA
    J Stud Alcohol Drugs; 2019 Mar; 80(2):245-251. PubMed ID: 31014470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial.
    Anderson AL; Li SH; Markova D; Holmes TH; Chiang N; Kahn R; Campbell J; Dickerson DL; Galloway GP; Haning W; Roache JD; Stock C; Elkashef AM
    Drug Alcohol Depend; 2015 May; 150():170-4. PubMed ID: 25818061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.
    Roche DJO; Worley MJ; Courtney KE; Bujarski S; London ED; Shoptaw S; Ray LA
    Psychopharmacology (Berl); 2017 Jul; 234(13):1997-2007. PubMed ID: 28357460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence.
    Heinzerling KG; Gadzhyan J; van Oudheusden H; Rodriguez F; McCracken J; Shoptaw S
    J Adolesc Health; 2013 Apr; 52(4):502-5. PubMed ID: 23333007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion attenuates methamphetamine self-administration in adult male rats.
    Reichel CM; Murray JE; Grant KM; Bevins RA
    Drug Alcohol Depend; 2009 Feb; 100(1-2):54-62. PubMed ID: 19010609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects.
    Johnson BA; Roache JD; Ait-Daoud N; Wallace C; Wells L; Dawes M; Wang Y
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):203-13. PubMed ID: 15850499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use.
    Heinzerling KG; Swanson AN; Hall TM; Yi Y; Wu Y; Shoptaw SJ
    Addiction; 2014 Nov; 109(11):1878-86. PubMed ID: 24894963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.